Objective and Function

The primary objective of the Controlled Substance Advisory Committee is to promote, preserve and protect the public health, safety and welfare by regulating and monitoring use and abuse of controlled substances. To meet this objective, the Committee:

• carries out a program of registration, inspection, investigation and education.
• recommends new/revised rules and regulations and disciplinary sanctions against registrants to the Secretary of State.

The Committee issues registrations to practitioners and facilities that prescribe, dispense, manufacture or distribute controlled substances. Practitioners include physicians, physician assistants, advanced practice registered nurses, podiatrists, dentists, optometrists, and veterinarians. Facilities include pharmacies, distributors, manufacturers, hospitals, clinics, researchers, laboratories and provider pharmacies.

To assist the Committee, the Drug Control Administrator for the Division of Professional Regulation is responsible for the Committee’s regular administrative functions.

The Committee’s authority is in 16 Del. C., Chapter 47 and the Uniform Controlled Substance Act Regulations.

Meetings

Unless notified otherwise, the Committee meets quarterly. All meetings are open to the general public. They are held in the Cannon Building at 861 Silver Lake Blvd. Suite 203, Dover, Delaware 19904. The meeting schedule is available at the State of Delaware public meeting calendar.

The Committee may need to review and approve your application for licensure and will only review a complete application. A complete application includes your application and any documentation submitted through DELPROS and/or any documents submitted through the mail or email from third-parties. The Committee will review your documentation at its next scheduled meeting.